Dichloropane
From Wikipedia, the free encyclopedia
 | |
|---|---|
| Systematic (IUPAC) name | |
| methyl (1R,2S,3S,5S)-3-(3,4-dichlorophenyl)-8-azabicyclo[3.2.1]octane-2-carboxylate | |
| Clinical data | |
| Legal status | ? |
| Identifiers | |
| CAS number | 146725-34-0  |
| ATC code | None |
| PubChem | CID 127024 |
| Chemical data | |
| Formula | C15H17Cl2NO2 |
| Mol. mass | 314.207 |
| SMILES
| |
| (what is this?) (verify) | |
Dichloropane ((-)-2β-Carbomethoxy-3β-(3,4-dichlorophenyl)tropane, RTI-111, O-401) is a powerful SNDRI with IC50 (nM) values of 0.79, 3.13, and 18 at the DAT, SERT, and NET.[1]
Methylecgonidine as the direct precursor to this compound.[2]
In contrast to the closely related RTI-112, dichloropane is a potent stimulant drug which produces similar effects to cocaine as well as being structurally similar to cocaine. In animal studies although, dichloropane had a slower onset and longer duration of action.[3][4]
Transporter selectivity for disubstituted analogs
| RTI | P | M | [3H]WIN 35,428 | [3H]Paroxetine | [3H]Nisoxetine |
|---|---|---|---|---|---|
| 111 | Cl | Cl | 0.79 | 3.13 (0.29) | 18 (11) |
| 112 | Cl | Me | 0.82 ± 0.05 | 10.5 ± 0.41 (0.95 ± 0.04) | 36.2 ± 1.02 (21.8 ± 0.62) |
| Cl | Br | 0.42 ± 0.02 | 0.78 ± 0.04 (0.19 ± 0.01) | 7.24 ± 0.69 (3.62 ± 0.34) | |
| Cl | I | 0.41 ± 0.09 | 1.39 ± 0.23 (0.34 ± 0.06) | 15.1 ± 0.59 (7.74 ± 0.29) | |
| Br | Cl | 0.12 ± 0.04 | 0.94 ± 0.09 (0.23 ± 0.02) | 1.31 ± 0.13 (0.65 ± 0.07) | |
| Br | Br | 0.27 ± 0.01 | 0.71 ± 0.03 (0.18 ± 0.01) | 2.80 ± 0.16 (1.10 ± 0.08) | |
| Br | I | 0.21 ± 0.06 | 1.14 ± 0.26 (0.25 ± 0.04) | 10.4 ± 1.5 (5.12 ± 0.77) | |
| I | Cl | 0.26 ± 0.05 | 1.04 ± 0.14 (0.63 ± 0.05) | 1.26 ± 0.09 (0.63 ± 0.05) | |
| I | Br | 0.20 ± 0.04 | 0.58 ± 0.07 (0.14 ± 0.02) | 1.96 ± 0.17 (0.98 ± 0.09) | |
| I | I | 0.98 ± 0.05 | 2.0 ± 0.56 (0.19 ± 0.05) | 40.4 ± 3.56 (24 ± 2.1) | |
| Me | Me | 0.43 ± 0.07 | 9.88 ± 1.11 (2.42 ± 0.27) | 107 ± 11 (44 ± 4.7) |
DAT: (p-Br, m-Cl) < (p-I, m-Br) ≈ (p-Br, m-I) ~ (p-I, m-Cl) ≈ p,m-Br2 < (p-Cl, m-I) ≈ (p-Cl, m-Br) ≈ p,m-Me2 < p,m-Cl2 < (p-Cl, m-Me) < p,m-I2.
5HT: (p-I, m-Br) < p,m-Br2 ~ (p-Cl, m-Br) < (p-Br, m-Cl) ~ (p-I, m-Cl) < (p-Br, m-I) < (p-Cl, m-I) < p,m-I2 < p,m-Cl2 < (p-Cl, m-Me) < p,m-Me2.
NET: (p-I, m-Cl) ~ (p-Br, m-Cl) < (p-I, m-Br) < p,m-Br2 < (p-Cl, m-Br) < (p-Br, m-I) < (p-Cl, m-I) < p,m-Cl2 < (p-Cl, m-Me) < p,m-I2 < p,m-Me2.
See also
References
- ↑ Carroll FI, Blough BE, Nie Z, Kuhar MJ, Howell LL, Navarro HA. Synthesis and Monoamine Transporter Binding Properties of 3-(3',4'-Disubstituted phenyl)tropane-2-carboxylic Acid Methyl Esters. J Med Chem. 2005 Apr 21;48(8):2767-71. PMID 15828814
- ↑ Carroll FI, Mascarella SW, Kuzemko MA, Gao Y, Abraham P, Lewin AH, Boja JW, Kuhar MJ. Synthesis, ligand binding, and QSAR (CoMFA and classical) study of 3 beta-(3'-substituted phenyl)-, 3 beta-(4'-substituted phenyl)-, and 3 beta-(3',4'-disubstituted phenyl)tropane-2 beta-carboxylic acid methyl esters. Journal of Medicinal Chemistry. 1994 Sep 2;37(18):2865-73. PMID 8071935
- ↑ Ranaldi R, Anderson KG, Carroll FI, Woolverton WL. Reinforcing and discriminative stimulus effects of RTI 111, a 3-phenyltropane analog, in rhesus monkeys: interaction with methamphetamine. Psychopharmacology (Berlin). 2000 Dec;153(1):103-10. PMID 11255920
- ↑ Cook CD, Carroll IF, Beardsley PM. Cocaine-like discriminative stimulus effects of novel cocaine and 3-phenyltropane analogs in the rat. Psychopharmacology (Berlin). 2001 Dec;159(1):58-63. PMID 11797070
| |||||||||||||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
This article is issued from Wikipedia. The text is available under the Creative Commons Attribution/Share Alike; additional terms may apply for the media files.